Profilo
Wenpei Su is Director of Genomic Applications for CeMines, Inc. He joined CeMines in July 2004.
He is responsible for the assimilation of pure molecular and immunome research.
He has 20 years of research and product development experience.
He was Senior Staff Scientist and Project Leader of Novartis Research Institute in 1999.
He received a PhD in molecular biology and biochemistry from Cornell University in 1994.
Precedenti posizioni note di Wenpei Su
| Società | Posizione | Fine |
|---|---|---|
CeMines, Inc.
 CeMines, Inc. Medical SpecialtiesHealth Technology CeMines, Inc. develops technology for the detection and treatment of cancer. The firm provides diagnostic tests for lung, breast, gastrointestinal, and leukemia. The company was founded by Richard Cavalli, Toomas Neuman and Kaia Palm in 2000 and is headquartered in Golden, CO. | Corporate Officer/Principal | - |
Formazione di Wenpei Su
| Cornell University | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
CeMines, Inc.
CeMines, Inc. Medical SpecialtiesHealth Technology CeMines, Inc. develops technology for the detection and treatment of cancer. The firm provides diagnostic tests for lung, breast, gastrointestinal, and leukemia. The company was founded by Richard Cavalli, Toomas Neuman and Kaia Palm in 2000 and is headquartered in Golden, CO. | Health Technology |
- Borsa valori
- Insiders
- Wenpei Su
